Inflammatory Response of Pulmonary Artery Smooth Muscle Cells Exposed to Oxidative and Biophysical Stress
Pulmonary hypertension in the neonate requires treatment with oxygen and positive pressure ventilation, both known to induce lung injury. The direct response of pulmonary artery smooth muscle cells, the most abundant cells in the artery wall, to the stress of positive pressure and hyperoxia has not been previously studied. Pulmonary artery smooth muscle cells were cultured in temperature- and pressure-controlled air-tight chambers under conditions of positive pressure or hyperoxia for 24 h. Control cells were cultured in room air under atmospheric pressure. After the exposure period, culture medium was collected and samples were analyzed by ELISA, Human Cytokine 25-Plex Panel using a Luminex 200 analyzer and Western blot. Secretion of various inflammatory mediators, specifically IL-6, IL-8, IL-2R, MIP-1β, MCP-1, IP-10, IL-7, IL-1RA, and IFN-α, was higher in the positive pressure and hyperoxia groups compared with control. The level of cyclin D1 was decreased in the hyperoxia and positive pressure group compared with control. Levels of fibronectin and α-smooth muscle actin were not different among the groups. Pulmonary artery smooth muscle cells directly produce multiple inflammatory mediators in response to oxidative and biophysical stress in vitro, which may be part of a cascade that leads to the vascular and perivascular changes in pulmonary hypertension.
KEY WORDShyperoxia inflammation positive pressure pulmonary hypertension
Support was provided in part by COBRE grant P20 GM 103464-Phase 2 from the NIGMS, a component of the NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.
Compliance with Ethical Standards
Conflicts of Interest
The authors declare that they have no conflicts of interest.
- 4.Collaco, J.M., L.H. Romer, B.D. Stuart, J.D. Coulson, A.D. Everett, E.E. Lawson, J.I. Brenner, A.T. Brown, M.K. Nies, P. Sekar, L.M. Nogee, and S.A. McGrath-Morrow. 2012. Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia. Pediatric Pulmonology 47: 1042–1053. https://doi.org/10.1002/ppul.22609.CrossRefPubMedPubMedCentralGoogle Scholar
- 7.Stenmark, K.R., B. Meyrick, N. Galie, W.J. Mooi, and I.F. McMurtry. 2009. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. American Journal of Physiology—Lung Cellular and Molecular Physiology 297: L1013–L1032. https://doi.org/10.1152/ajplung.00217.2009. CrossRefPubMedGoogle Scholar
- 11.Pinto, R.F., L. Higuchi Mde, and V.D. Aiello. 2004. Decreased numbers of T-lymphocytes and predominance of recently recruited macrophages in the walls of peripheral pulmonary arteries from 26 patients with pulmonary hypertension secondary to congenital cardiac shunts. Cardiovascular Pathology: the Official Journal of the Society for Cardiovascular Pathology 13: 268–275.CrossRefGoogle Scholar
- 12.Humbert, M., G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simonneau, and D. Emilie. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 151: 1628–1631.CrossRefPubMedGoogle Scholar
- 13.Soon, E., A.M. Holmes, C.M. Treacy, N.J. Doughty, L. Southgate, R.D. Machado, R.C. Trembath, S. Jennings, L. Barker, P. Nicklin, C. Walker, D.C. Budd, J. Pepke-Zaba, and N.W. Morrell. 2010. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension. Circulation 122: 920–927. https://doi.org/10.1161/CIRCULATIONAHA.109.933762.CrossRefPubMedGoogle Scholar
- 14.Sanchez, O., E. Marcos, F. Perros, E. Fadel, L. Tu, M. Humbert, P. Dartevelle, G. Simonneau, S. Adnot, and S. Eddahibi. 2007. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine 176: 1041–1047.CrossRefPubMedGoogle Scholar
- 16.Yee, M., R.J. White, H.A. Awad, W.A. Bates, S.A. McGrath-Morrow, and M.A. O’Reilly. 2011. Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice. American Journal of Pathology 178: 2601–2610. https://doi.org/10.1016/j.ajpath.2011.02.010.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Wu, S., L. Capasso, A. Lessa, J. Peng, K. Kasisomayajula, M. Rodriguez, et al. 2008. High tidal volume ventilation activates Smad2 and upregulates expression of connective tissue growth factor in newborn rat lung. Pediatric Research 63: 245–250. doi: https://doi.org/10.1203/PDR.0b013e318163a8cc.
- 18.Alapati, D., M. Rong, S. Chen, D. Hehre, S.C. Hummler, and S. Wu. 2014. Inhibition of β-catenin signaling improves alveolarization and reduces pulmonary hypertension in experimental bronchopulmonary dysplasia. American Journal of Respiratory Cell and Molecular Biology 51: 104–113. https://doi.org/10.1165/rcmb.2013-0346OC.CrossRefPubMedGoogle Scholar
- 19.Alapati, D., M. Rong, S. Chen, D. Hehre, M.M. Rodriguez, K.E. Lipson, and S. Wu. 2011. Connective tissue growth factor antibody therapy attenuates hyperoxia-induced lung injury in neonatal rats. American Journal of Respiratory Cell and Molecular Biology 45: 1169–1177. https://doi.org/10.1165/rcmb.2011-0023OC.CrossRefPubMedGoogle Scholar
- 20.Humbert, M., N.W. Morrell, S.L. Archer, K.R. Stenmark, M.R. MacLean, I.M. Lang, B.W. Christman, E.K. Weir, O. Eickelberg, N.F. Voelkel, and M. Rabinovitch. 2004. Cellular and molecular pathobiology of pulmonary arterial hypertension. Journal of the American College of Cardiology 43: 13S–24S.CrossRefPubMedGoogle Scholar
- 22.Menendez, C., L. Martinez-Caro, L. Moreno, N. Nin, J. Moral-Sanz, D. Morales, A. Cogolludo, A. Esteban, J.A. Lorente, and F. Perez-Vizcaino. 2013. Pulmonary vascular dysfunction induced by high tidal volume mechanical ventilation. Critical Care Medicine 41: e149–e155. https://doi.org/10.1097/CCM.0b013e318287ef4a. CrossRefPubMedGoogle Scholar
- 24.Eddahibi, S., C. Guignabert, A.M. Barlier-Mur, L. Dewachter, E. Fadel, P. Dartevelle, M. Humbert, G. Simonneau, N. Hanoun, F. Saurini, M. Hamon, and S. Adnot. 2006. Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. Circulation 113: 1857–1864.CrossRefPubMedGoogle Scholar
- 25.Tanaka, A., Y. Jin, S.J. Lee, M. Zhang, H.P. Kim, D.B. Stolz, S.W. Ryter, and A.M.K. Choi. 2012. Hyperoxia-induced LC3B interacts with the Fas apoptotic pathway in epithelial cell death. American Journal of Respiratory Cell and Molecular Biology 46: 507–514. https://doi.org/10.1165/rcmb.2009-0415OC.CrossRefPubMedPubMedCentralGoogle Scholar
- 27.Humbert, M., D. Montani, F. Perros, P. Dorfmüller, S. Adnot, and S. Eddahibi. 2008. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. Vascular Pharmacology 49: 113–118. https://doi.org/10.1016/j.vph.2008.06.003.CrossRefPubMedGoogle Scholar
- 28.Berkelhamer, S.K., G.A. Kim, J.E. Radder, S. Wedgwood, L. Czech, R.H. Steinhorn, and P.T. Schumacker. 2013. Developmental differences in hyperoxia-induced oxidative stress and cellular responses in the murine lung. Free Radical Biology and Medicine 61: 51–60. https://doi.org/10.1016/j.freeradbiomed.2013.03.003.CrossRefPubMedGoogle Scholar
- 31.Gourh, P., F.C. Arnett, S. Assassi, F.K. Tan, M. Huang, L. Diekman, M.D. Mayes, J.D. Reveille, and S.K. Agarwal. 2009. Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations. Arthritis Research & Therapy 11: R147. https://doi.org/10.1186/ar2821.CrossRefGoogle Scholar
- 38.Ikonomidis, I., J.P. Lekakis, M. Nikolaou, I. Paraskevaidis, I. Andreadou, T. Kaplanoglou, P. Katsimbri, G. Skarantavos, P.N. Soucacos, and D.T. Kremastinos. 2008. Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis. Circulation 117: 2662–2669. https://doi.org/10.1161/CIRCULATIONAHA.107.731877.CrossRefPubMedGoogle Scholar
- 40.Lin, S.J., H.T. Yen, Y.H. Chen, H.H. Ku, F.Y. Lin, and Y.L. Chen. 2003. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. Journal of Cellular Biochemistry 88: 836–847.CrossRefPubMedGoogle Scholar
- 41.Wilson, J., J. Yu, L. Taylor, and P. Polgar. 2015. Hyperplastic growth of pulmonary artery smooth muscle cells from subjects with pulmonary artery hypertension is activated through JNK and p38 MAPK. PLoS One 10 (4): e0123662. https://doi.org/10.1371/journal.pone.0123662.CrossRefPubMedPubMedCentralGoogle Scholar
- 43.QI, Y.X., X.H. Jiang, X.D. Wang, et al. 2011. PDGF-BB and TGF-β on crosstalk between endothelial and smooth muscle cells in remodeling induced by low shear stress. Proceedings of the National Academy of Science of the United States 108: 1908–1913. https://doi.org/10.1073/pnas.1019219108.CrossRefGoogle Scholar